Literature DB >> 9710890

Interleukin-1 receptor antagonist.

B Bresnihan1, G Cunnane.   

Abstract

There are three members of the IL-1 gene family: IL-1 alpha, IL-1 beta, and IL-1ra, IL-1 alpha, and IL-1 beta are both antagonist molecules with many proinflammatory effects. IL-1ra is an antagonist molecule that can inhibit the effect of IL-1 alpha and IL-1 beta by specifically blocking the IL-1 receptor on target effector cells. IL-1 alpha and IL-1 beta are considered to be pivotal cytokines in the pathogenesis of many inflammatory diseases. Anti-IL-1 treatment has been shown to cause amelioration of arthritis in animal models and in RA, suggesting that IL-1ra may be an important therapeutic option in the future management of RA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9710890     DOI: 10.1016/s0889-857x(05)70029-6

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  16 in total

Review 1.  Sepsis-induced immunosuppression: from bad to worse.

Authors:  R C Reddy; G H Chen; P K Tekchandani; T J Standiford
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  New therapies for rheumatoid arthritis.

Authors:  F Goldblatt; D A Isenberg
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

Review 3.  Progress in the use of biochemical and biological markers for evaluation of rheumatoid arthritis.

Authors:  R M Nakamura
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

4.  Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation.

Authors:  Jens Lutz; Klaus Thürmel; Uwe Heemann
Journal:  J Inflamm (Lond)       Date:  2010-05-28       Impact factor: 4.981

5.  Effect of calcium hydroxide on proinflammatory cytokines and neuropeptides.

Authors:  Asma A Khan; Xiaoling Sun; Kenneth M Hargreaves
Journal:  J Endod       Date:  2008-09-17       Impact factor: 4.171

6.  The effect of covalently immobilized rhIL-1ra-ELP fusion protein on the inflammatory profile of LPS-stimulated human monocytes.

Authors:  Dong-Hwan Kim; Jason T Smith; Ashutosh Chilkoti; William M Reichert
Journal:  Biomaterials       Date:  2007-04-12       Impact factor: 12.479

7.  The Development of Novel Therapies for Rheumatoid Arthritis.

Authors:  Ling-Dong Quan; Geoffrey M Thiele; Jun Tian; Dong Wang
Journal:  Expert Opin Ther Pat       Date:  2008-07       Impact factor: 6.674

8.  Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet's disease.

Authors:  Nurşen Düzgün; Ergin Ayaşlioğlu; Hüseyin Tutkak; Olcay T Aydintuğ
Journal:  Rheumatol Int       Date:  2003-11-05       Impact factor: 2.631

9.  Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist.

Authors:  Ming-Ling Tsai; Chi-Ting Horng; Show-Li Chen; Xiao Xiao; Chih-Hung Wang; Yeou-Ping Tsao
Journal:  Mol Vis       Date:  2009-08-08       Impact factor: 2.367

10.  Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies.

Authors:  Steven J Greco; Pranela Rameshwar
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.